Lansoprazol Actavis

Lansoprazole, the active ingredient in Lansoprazol Actavis, is a proton pump inhibitor presented as an oral dosage form for gastro‑enteral use. It reduces gastric acid secretion and is employed in the management of acid‑related gastrointestinal disorders in adults and adolescents. GNH USA supplies Lansoprazol Actavis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor used to treat conditions associated with excess gastric acid production. - Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence by lowering gastric acidity. - Helicobacter pylori eradication regimens: acts as a component of combination therapy to improve bacterial eradication rates. - Zollinger‑Ellison syndrome: controls hyper‑secretion of acid in this rare endocrine disorder.

Adverse reactions may occur with lansoprazole use.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: occasional feeling of queasiness after dosing. - Abdominal pain: mild discomfort in the upper abdomen.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or difficulty breathing requiring immediate medical attention. - Clostridioides difficile infection: persistent watery diarrhea and abdominal cramping. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures in prolonged use. - Bone fractures: increased risk with long‑term therapy, especially in elderly patients.

Before initiating lansoprazole therapy, consider the following precautions. - Assess renal and hepatic function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for reduced efficacy of drugs requiring acidic pH for absorption. - Monitor long‑term use: evaluate need for continued therapy after 12 months to mitigate fracture risk. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazole may interact with several medicines, altering their effectiveness or safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity; consider alternative antiplatelet agents. - Atazanavir: markedly decreased antiviral absorption; avoid co‑administration.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation parameters regularly. - Methotrexate (high dose): may increase serum levels; check for toxicity. - Digoxin: enhanced absorption; monitor serum digoxin concentrations.